Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Posey

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53Jonathan D Lee, Bridget L Menasche, Maria Mavrikaki, et al.
Cell Reports|November 22, 2023
Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53Jonathan D Lee, Bridget L Menasche, Maria Mavrikaki, et al.
Plos One|August 23, 2012
A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulationMichelle L Scalley-Kim, Bruce W Hess, Ryan L Kelly, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53Jonathan D Lee, Bridget L Menasche, Maria Mavrikaki, et al.
Cell Reports|November 22, 2023
Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53Jonathan D Lee, Bridget L Menasche, Maria Mavrikaki, et al.
Plos One|August 23, 2012
A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulationMichelle L Scalley-Kim, Bruce W Hess, Ryan L Kelly, et al.
Pageof 4